Article Details
Retrieved on: 2021-07-19 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Suvratoxumab monoclonal antibody (mAb) for prevention of pneumonia has been licensed from AstraZeneca. Suvratoxumab extends Aridis' ...
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here